MarginsXMarginsX
Home › Markets › PBSV

Pharma-Bio Serv, Inc. (PBSV)

PBSV is quoted over the counter, not listed on an exchange. Pharma-Bio Serv, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Last trade · November 9, 2026
$0.5000
No trades since Nov 9, 2026; later closes repeat the last quote
1-year return
-7.4%
Market cap
$11.5M
Nano cap. From the Nov 9, 2026 last trade × 22.9M shares (10-Q cover page, Sep 10, 2026)
P/E and P/S
45.5× · 1.2×
On trailing twelve months to July 31, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerPBSV, quoted over the counter
SEC CIK0001304161
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codeServices-Management Consulting Services
Business addressDorado, PR

Warning signs

Cash runway
43.9 months
$1.5M cash at July 31, 2026
Share count, 1 year
-0.1%
2025-09-10 to 2026-09-10 · -0.3% over 3 years
Going-concern doubt
No
10-Q filed September 14, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-09-14
Cash and burn$1.5M cash; operating cash flow -$104K a quarter.Report 2026-07-31
Shares outstanding22,901,692 (2026-09-10); 22,918,092 a year earlier; 22,963,451 three years earlier.Cover page 2026-09-10
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorCrowe PR PSC, Guaynabo, Puerto Rico, United StatesPCAOB Form AP 2026-02-07
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-07-31
$2.3M-$14K$61K$1.5MNo debt tags$9.5M10-Q 2026-09-14
Q2 2026
2026-04-30
$2.7M$233K-$365K$1.8MNo debt tags$9.1M10-Q 2026-06-15
Q1 2026
2026-01-31
$2.3M$33K-$390K$5.8MNo debt tags$8.8M10-Q 2026-03-17
Q4 2025
2025-10-31
$2.1M-$102$280K$3.4MNo debt tags$9.0M10-K 2026-01-29
Q3 2025
2025-07-31
$2.0M-$204K$237K$4.0MNo debt tags$9.2M10-Q 2026-09-14
Q2 2025
2025-04-30
$2.4M$95K-$302K$2.1MNo debt tags$9.6M10-Q 2026-06-15
Q1 2025
2025-01-31
$2.5M$9K-$429K$7.3MNo debt tags$9.6M10-Q 2026-03-17
Q4 2024
2024-10-31
$2.3M$16K$78K$6.8MNo debt tags$9.5M10-K 2026-01-29

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32009-05-05
Latest annual report10-K/A2026-02-27
Latest quarterly / interim10-Q2026-09-14
Latest current report8-K2026-09-14
Latest proxyDEF 14A2026-04-16

Source: SEC EDGAR submissions feed, 527 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier